StockData
Integra LifeSciences Holdings Corp logo

Integra LifeSciences Holdings Corp (IART) stock

IARTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 9/308% below fair value
$13.55−0.43 (-3.08%)

Close on Nov 17, 2026Market cap $1.05BP/E 79.7Yield –

Integra LifeSciences EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Integra LifeSciences's EV/EBITDA was 13.2× on Nov 11, 2026, against 56.4× a year earlier. Over the last 5 years it ranged from 10.8× to 82.1×, with a median of 22.8×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202613.2×−68.8
2025Jul 31, 202582.1×+30.8
2024Dec 31, 202451.3×+28.3
2023Dec 29, 202322.9×+4.6
2022Dec 30, 202218.4×−9.0
2021Dec 31, 202127.3×−10.8
2020Dec 31, 202038.2×+14.2
2019Dec 31, 201924.0×+5.9
2018Dec 31, 201818.1×−2.8
2017Dec 29, 201720.8×+1.5
2016Dec 30, 201619.4×+3.3
2015Dec 31, 201516.1×+5.0
2014Dec 31, 201411.1×−16.1
2013Dec 31, 201327.2×+19.6
2012Dec 31, 20127.7×+1.6
2011Dec 30, 20116.0×−2.3
2010Dec 31, 20108.4×−1.4
2009Dec 31, 20099.8×–

More Integra LifeSciences figures

See a number that looks wrong?